The burden of malignant melanoma--lessons to be learned from Austria. Read more about The burden of malignant melanoma--lessons to be learned from Austria.
The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model. Read more about The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model.
Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer. Read more about Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer.
Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG). Read more about Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG).
Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumours. Read more about Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumours.
A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcoma. Read more about A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcoma.
Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up study. Read more about Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up study.
International variation in management of screen-detected ductal carcinoma in situ of the breast. Read more about International variation in management of screen-detected ductal carcinoma in situ of the breast.
Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network. Read more about Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network.
Adverse impact of regional lymph node involvement in osteosarcoma. Read more about Adverse impact of regional lymph node involvement in osteosarcoma.
